Biotechnology News

May 8, 2012

WEST CORNWALL, Conn. & NORRISTOWN, Pa.--(BUSINESS WIRE)--One Eleven Software & M3 Health Announce Alliance to develop next generation of pharmaceutical e-sampling and m-health tools.

May 8, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics Reports First Quarter 2012 Results

May 8, 2012

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics today reported results for its fiscal 2012 second quarter and announced that its Board of Directors has authorized the repurchase of up to $50 million of its outstanding common stock.

May 8, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present at the Bank of America Merrill Lynch 2012 Health Care Conference on Tuesday, May 15, 2012 at 3:40 p.m. Pacific Time (6:40 p.m. Eastern Time) at Encore...

May 8, 2012

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTCBB: TBIO) today reported financial results for the three months ended, March 31, 2012, and provided a business update. “We made progress in the first quarter validating and advancing several of...

May 8, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today reported its financial results for the first quarter of 2012. The company maintained its strong financial condition while continuing to advance its clinical...

May 8, 2012

ALBUQUERQUE, N.M. & FRAMINGHAM, Mass.--(BUSINESS WIRE)--TruTouch Technologies, a pioneer in non-invasive alcohol intoxication and biometric measurement systems, recently named David Desrochers as the Chief Financial Officer. Mr. Desrochers...

May 8, 2012

BOSTON--(BUSINESS WIRE)--Sorin Group announced at Heart Rhythm 2012 FDA approval and commercial launch of the PARADYM™ RF ICD and CRT-D devices that are designed to be monitored remotely

May 8, 2012

MINNEAPOLIS--(BUSINESS WIRE)--Increasing patient access to endovascular repair of aortic aneurysms worldwide, Medtronic, Inc. (NYSE: MDT) is expanding availability of the Valiant® Captivia® Thoracic Stent Graft System in several countries,...

May 8, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Earlier communication between payers and pharmaceutical companies can reduce tension and help foster more win-win market access strategies, according to a new study from Cutting Edge Information.

May 8, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--The Broad Institute and Fluidigm (NASDAQ:FLDM) launched a new research center dedicated to accelerating the development of research methods and discoveries in mammalian single-cell genomics.

May 8, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--GE Healthcare today announced that additional supply for Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP) has been made available from its contract manufacturer to meet the current...

May 8, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Vascular Closure Systems, Inc. Announces Conclusion of Phase I of the First in Human (FIH) Use of the FastSeal® Bioabsorbable Vascular Access Closure System

May 8, 2012

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTCBB: TBIO) today announced the following Webcast: What:   Transgenomic, Inc. First Quarter 2012 Financial Results and Business Update Conference Call   When: Tuesday, May 8, 2012 @ 5:00 p.m....

May 8, 2012

NATICK, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics announced that the CorPath® PRECISE Trial has been selected as a late breaking clinical trial at the 2012 SCAI Scientific Sessions.

May 8, 2012

SILVER SPRING, Md.--(BUSINESS WIRE)--Nuvilex Inc. (OTCQB:NVLX) reports Dr. Gunzburg of SG Austria participated in meetings with Japanese biotech and pharmaceutical companies after Kyoto Meeting

May 8, 2012

JERUSALEM--(BUSINESS WIRE)--Oramed Pharmaceuticals announced that its wholly owned Israeli subsidiary, Oramed Ltd., was awarded a government grant from the Office of the Chief Scientist

May 8, 2012

DAVIS, Calif.--(BUSINESS WIRE)--Gold Standard Diagnostics, Corp. has over 200 “ThunderBolt-Ready” assay protocols for Autoimmune, Oncology, Infectious Disease, Endocrinology and Cardiovascular available. Simplify your lab.

May 8, 2012

CLEVELAND--(BUSINESS WIRE)--ChanTest Corporation sponsors May 19 Great Strides Walks in Northern Ohio in support of the Cystic Fibrosis Foundation’s annual fund-raising event. ChanTest employees walk at the Cleveland Zoo.

May 8, 2012

ROANOKE, Va.--(BUSINESS WIRE)--Luna Innovations Incorporated (NASDAQ: LUNA), a leading developer of fiber-optic sensing technology, today announced a development agreement with Philips Healthcare, to conduct work in advancing Luna’s technology...

May 8, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, based on clinical data and the opinions of interviewed thought leaders, FOLFIRI*...

May 8, 2012

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced that David P. King, Chairman and Chief Executive Officer, is scheduled to speak at the Bank of America Merrill Lynch 2012 Health...

May 8, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer Unveils Search Genius™ Software for Use With Microsoft® SharePoint® Framework, enable researchers to search, save and share data more easily for greater productivity

May 8, 2012

NEW YORK--(BUSINESS WIRE)--Medidata Solutions, today announced Glen de Vries, president and Cory Douglas will present at Jefferies 2012 Global Technology, Internet, Media and Telecom Conference

May 8, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Allenex (STO:ALNX) has today issued the Interim report January - March 2012 · Net sales for the quarter were SEK 30.0 million (20.5), an increase of 46 percent year on year. (Olerup GmbH was not a part...

May 8, 2012

NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics’ LuViva® Advanced Cervical Scan Combined with HPV Testing Could Optimize Cervical Cancer Detection; Reduce Overtreatment of False Positives by Approximately 33%

May 8, 2012

CHICAGO--(BUSINESS WIRE)--ClearTrial 4.5 was awarded Best of Show at the Bio-IT World Conference & Expo 2012. The Best of Show Award “distinguishes and highlights products from the competition,” according to Bio-IT World.

May 8, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Ivivi Health Sciences, LLC, an medical technology company that designs, develops and markets non-invasive anti-inflammatory and regenerative technologies, has announced new leadership appointments

May 8, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval of its Assura™ portfolio of implantable cardioverter defibrillators (ICDs) and...

May 8, 2012

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Peter Kellogg, executive vice president and chief financial officer and Nancy Thornberry, senior vice president...

May 8, 2012

SARATOGA, Calif.--(BUSINESS WIRE)--UCSF's Dr. Jonah Chan joins the Myelin Repair Foundation's Research Consortium for Myelin Repair and Multiple Sclerosis Research

May 8, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology Announces First Quarter 2012 Operating Results

May 8, 2012

OTTAWA, Ontario--(BUSINESS WIRE)--David Allan, founding Chairman of YM BioSciences and its 13-year CEO is being recognized by the industry in BIOTECanada’s naming him as recipient of the Gold Leaf Award for Industry Leadership.

May 8, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a...

May 8, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Blueprint Medicines, a company harnessing the understanding of the molecular blueprint of cancer to develop personalized, highly-selective cancer therapies, today announced the addition of George Demetri, M.D.,...

May 8, 2012

BOSTON--(BUSINESS WIRE)--Partnering to acquire key capabilities like local market knowledge, access, networks & government support is the most important factor for formulation and delivery players, according to Lux Research.

May 8, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: DiaGenic ASA [OSL:DIAG] have received grants of world-wide trademark for key brand names in the DiaGenic portfolio: ADtect®, MCItect®, PDtect® and BCtect®. Trademark protection adds to building a...

May 8, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals is announcing their participation at the Bank of America 2012 Health Care Conference on Tuesday, May 15th.

May 8, 2012

PARIS--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, will unveil its new OneShot™ renal denervation system at the EuroPCR congress in Paris, France, on May 16, 2012.

May 8, 2012

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NYSE Amex: AIS) today reported financial and operating results for the first quarter ended March 31, 2012. Quarter and Recent Highlights Increased total revenue 92% and product revenue 78% to $6...

May 8, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis enrolls patients in CRUK Phase 1/2 trial in head and neck cancer

May 8, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Secured $20 million and expanded Series A financing with an additional investor, Jafco Co., Ltd, proceeds to advance, EBI-005, into clinic development for dry eye disease

May 8, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven Biotherapeutics presents data at ARVO demonstrating optimal properties of EBI-005, first rationally-designed, IL-1 inhibitor protein for topical administration optimized for ocular disorders.

May 8, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) today provided a Company update and reported financial results for the first quarter of 2012. “Our team successfully addressed FDA’s concerns about Capesaris, and we expect to initiate our...

May 8, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) announced today that the Food and Drug Administration (FDA) removed its Full Clinical Hold on the Company’s Investigational New Drug application for Capesaris® following the review by the...

May 8, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted antibody-based anticancer products, today announced that the following presentations by Company management at upcoming investor...

May 8, 2012

BEIJING--(BUSINESS WIRE)--Origin Agritech Limited (NASDAQ: SEED) (“Origin”, the “Company”, “us” or “our”) , a technology-focused supplier of hybrid and genetically modified crop seeds in China, today announced unaudited financial results for the...

May 8, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that CEO Frank Reynolds is scheduled to appear on...

May 8, 2012

SEATTLE--(BUSINESS WIRE)--In collaboration with the University of Washington and the University of Texas Medical Branch at Galveston, Seattle-based biotech company, Kineta, Inc. announced a new $8.1 million biodefense grant to develop new drugs...